To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

Mise à jour : Il y a 4 ans
Référence : NCT00946114

Femme et Homme

  • | Pays :
  • Poland
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to provide sildenafil therapy to eligible adult patients with pulmonary arterial hypertension (PAH) and to the patients who completed the A1481142 study for the treatment of PAH in Poland. Only safety and tolerability data will be collected in these patients.


Critère d'inclusion

  • pulmonary hypertension

Liens